‘It really is noteworthy that the world’s most prestigious urology society has recognized the clinical significance of PTNS in their OAB treatment guidelines,’ said David Kaysen, CEO and President of Uroplasty.S. Private payers and Medicare carriers as we continue our initiatives to expand insurance for our Urgent Personal computer Neuromodulation System.’.. AUA includes percutaneous tibial nerve stimulation in OAB treatment guidelines Uroplasty, Inc. , a medical device organization that develops, manufactures and markets innovative proprietary items for the treating voiding dysfunctions, today announced that the American Urological Association issued a scientific guideline titled ‘Analysis and Treatment of Overactive Bladder in Adults,’ which include percutaneous tibial nerve stimulation as a fundamental element of the care path for overactive bladder treatment.The P-CAP arm demonstrated a greater than 60 percent improvement in OS, a more than doubling of median TTP, and almost a doubling of the %age of sufferers attaining SD or better. Furthermore, the ORR was 20 percent in the P-CAP arm versus 7 percent in the CAP arm. The final efficacy results are as follows: All evaluable sufferers> Of notable curiosity were the sufferers who had been previously refractory to a 5-FU structured regimen. The P-CAP arm again demonstrated a statistically significant increase in both TTP and OS when compared to CAP arm. The final data is usually illustrated below: 5-FU refractory sufferers> All 38 patients were evaluable for safety.